RENIBUS THERAPEUTICS, INC.

Profile

Company Names

RENIBUS THERAPEUTICS, INC.

Addresses

181 GRAND AVE., SUITE 225, SOUTHLAKE, TX 76092

181 GRAND AVENUE, SUITE 225, SOUTHLAKE, TX 76092

950 E. STATE HIGHWAY 114, STE-160, SOUTHLAKE, TX 76092

950 E. STATE HIGHWAY 114, SUITE 160, SOUTHLAKE, TX 76092

727 LATHROP STREET, LANTANA, TX 76226

Phone Numbers

386-527-1071
817.722.5768
469-688-3174

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$180,141,676.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-05-25 
$110,895,239.00 
$110,895,239.00 
$0.00 
Equity 
4
2022-07-15 
$23,413,102.00 
$25,000,000.00 
$1,586,898.00 
 
3
2019-09-12 
$34,614,335.00 
$34,614,335.00 
$0.00 
Equity 
2
2016-02-10 
$10,919,000.00 
$12,500,000.00 
$1,581,000.00 
Equity 
1
2016-02-09 
$300,000.00 
$300,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
NELS 
 
BERGMARK 
EXECUTIVE OFFICER
ZS PHARMA, INC.   |  RENIBUS THERAPEUTICS, INC.
JAMIE 
 
DONADIO 
EXECUTIVE OFFICER
RENIBUS THERAPEUTICS, INC.
ALVARO 
 
GUILLEM 
EXECUTIVE OFFICER, DIRECTOR
ONCONANO MEDICINE, INC.   |  RENIBUS THERAPEUTICS, INC.   |  NANOSCOPE THERAPEUTICS, INC.
CARLOS 
 
GUILLEM 
DIRECTOR, EXECUTIVE OFFICER
RENIBUS THERAPEUTICS, INC.
DALE 
 
JONES 
DIRECTOR
RENIBUS THERAPEUTICS, INC.   |  SV-DVS HOLDINGS, LLC   |  TEX SCOPE LLC   |  TEXNAN B LLC   |  TEXCAG A2P LLC   |  TREN 2 LLC   |  TREN 3 LLC   |  TEXSCOPE B LLC   |  TREN 4 LLC   |  TEXCAG SAFCAP LLC   |  TEXSCOPE C LLC   |  OUTSET MEDICAL, INC.   |  TEXNAN C LLC
HARPREET 
 
KAUR 
EXECUTIVE OFFICER, DIRECTOR
RENIBUS THERAPEUTICS, INC.
D. 
JEFFREY 
KEYSER 
DIRECTOR, EXECUTIVE OFFICER
RENIBUS THERAPEUTICS, INC.
JOCELYN 
 
KEYSER 
DIRECTOR
RENIBUS THERAPEUTICS, INC.
HENRIK 
 
RASMUSSEN 
DIRECTOR
RENIBUS THERAPEUTICS, INC.   |  SECRETOME THERAPEUTICS, INC.
JENNIFER 
D. 
RASMUSSEN 
DIRECTOR
RENIBUS THERAPEUTICS, INC.
BHUPINDER 
 
SINGH 
DIRECTOR, EXECUTIVE OFFICER
RENIBUS THERAPEUTICS, INC.
FRANK 
 
STONEBANKS 
EXECUTIVE OFFICER, DIRECTOR
CYNVEC LLC   |  TRIPHASE ACCELERATOR G.P. CORP   |  RENIBUS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-07-17
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-25 
2023-09-18
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-25 
2023-06-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-05-25 
2022-08-22
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2022-07-15 
2022-07-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2022-07-15 
2022-02-18
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-12 
2020-07-15
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-12 
2019-11-19
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-12 
2019-09-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-12 
2016-05-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
2016-04-12
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
2016-03-23
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
2016-02-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
2016-02-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SALEM PARTNERS LLC
43363
NONE
NONE
MELIOR CAPITAL MANAGEMENT GMBH
NONE